News

FDA endorses first-of-its-kind blood test for Alzheimer’s disease
The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less ...
First blood test for Alzheimer’s diagnosis cleared by FDA
The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...
FDA greenlights marketing of first Alzheimer's blood test for some patients
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
The FDA clears the first blood test for diagnosing Alzheimer's disease
There's a new way to screen for early detection of Alzheimer's disease. On Friday, the Food and Drug Administration (FDA) ...
US FDA clears first blood test for Alzheimer's detection
The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the ...
MedPage Today2d
FDA Clears First Blood Test for Alzheimer's Diagnosis
The blood test, known as the Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio, can be used to detect amyloid plaques ...
Honolulu Star-Advertiser2d
FDA clears first blood test for Alzheimer’s detection
The Food and Drug Administration has cleared Fujirebio Diagnostics’ blood test to diagnose Alzheimer’s disease, the regulator ...
US FDA clears first blood test to detect Alzheimer's disease
The U.S. Food and Drug Administration said on Friday it had cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's ...
FDA clears first blood test to detect Alzheimer's disease. What to know about Lumipulse.
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.
Express Healthcare2h
FDA approves first blood test to support Alzheimer’s diagnosis
The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood ...
Fierce Biotech2d
FDA clears its first blood test for diagnosing Alzheimer's disease, with Fujirebio's Lumipulse
The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...
Medscape2d
FDA Clears First Diagnostic Blood Test for Alzheimer's Disease
The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in symptomatic adults 55 years and older.